S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q3 2021

BVF Partners

Period: Q3 2021 Β· Filed: 2021-11-15
View on SEC EDGAR β†—
AUM
$2.56B
Total portfolio value
Positions
75
Reported securities
Top Holding
GHRS
8.0% $204.6M
QoQ Changes
+8 / -5
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-11-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
GHRSGH RESEARCH PLC$204.6M7.98%$22.06$27.01+22.4%
8.0%
KYMRKYMERA THERAPEUTICS INC$186.8M7.29%$58.74$113.51+93.2%
7.3%
OLMAOLEMA PHARMACEUTICALS INC$183.6M7.16%$27.56$12.64-54.1%
7.2%
RCUSARCUS BIOSCIENCES INC$112.6M4.39%$34.87$30.33-13.0%
4.4%
MERUS N V$111.3M4.34%β€”β€”
4.3%
ARGXARGENX SE$110.6M4.31%$302.00$939.68+211.2%
4.3%
RPTXREPARE THERAPEUTICS INC$97.7M3.81%β€”β€”
3.8%
XOMAXOMA CORP DEL$87.4M3.41%$24.75$43.00+73.7%
3.4%
PTGXPROTAGONIST THERAPEUTICS INC$69.1M2.70%$17.72$131.62+642.8%
2.7%
LXRXLEXICON PHARMACEUTICALS INC$69.1M2.69%$4.81$2.32-51.8%
2.7%
RVMDREVOLUTION MEDICINES INC$68.4M2.67%$27.51$189.24+587.9%
2.7%
RLAYRELAY THERAPEUTICS INC$64.6M2.52%$31.53$18.65-40.9%
2.5%
LKFTGALAPAGOS NV$58.9M2.30%$52.61$30.39-42.2%
2.3%
AMRNXXXXAMARIN CORP PLC$58.2M2.27%β€”β€”
2.3%
FDMT4D MOLECULAR THERAPEUTICS IN$54.1M2.11%$26.97$13.00-51.8%
2.1%
SNDXSYNDAX PHARMACEUTICALS INC$47.5M1.85%$19.11$21.82+14.2%
1.9%
ACIUAC IMMUNE SA$46.5M1.82%$6.71$2.51-62.6%
1.8%
VSTMXXXXVERASTEM INC$46.1M1.80%β€”β€”
1.8%
RAINRAIN THERAPEUTICS INC$44.3M1.73%β€”$1.97
1.7%
WHWKAADI BIOSCIENCES INC$33.7M1.31%$29.37$4.19-85.7%
1.3%
SPROSPERO THERAPEUTICS INC$33.3M1.30%$18.41$2.20-88.0%
1.3%
KURAKURA ONCOLOGY INC$30.6M1.19%$18.73$11.10-40.7%
1.2%
TYRATYRA BIOSCIENCES INC$29.8M1.16%$17.59$30.62+74.1%
1.2%
INFIQINFINITY PHARMACEUTICALS INC$28.7M1.12%$3.42$0.00
1.1%
PIRSPIERIS PHARMACEUTICALS INC$27.6M1.07%β€”β€”
1.1%
REPLREPLIMUNE GROUP INC$27.5M1.07%$29.64$11.58-60.9%
1.1%
CTICCTI BIOPHARMA CORP$26.3M1.03%β€”β€”
1.0%
VIRXVIRACTA THERAPEUTICS INC$24.8M0.97%β€”β€”
1.0%
ACRSACLARIS THERAPEUTICS INC$24.7M0.96%$18.00$5.56-69.1%
1.0%
XENEXENON PHARMACEUTICALS INC$24.0M0.94%$15.28$60.96+298.9%
0.9%

Quarter-on-Quarter Activity

Q3 2021 vs. Q2 2021

New Positions (8)

TickerIssuerNotionalSince Filing
MERUS N V$111.3M
LKFTGALAPAGOS NV$58.9M-42.2%
WHWKAADI BIOSCIENCES INC$33.7M-85.7%
TYRATYRA BIOSCIENCES INC$29.8M+74.1%
PNTPOINT BIOPHARMA GLOBAL INC$21.3M
ALPNALPINE IMMUNE SCIENCES INC$17.0M
NUVLNUVALENT INC$10.1M
MIRMMIRUM PHARMACEUTICALS INC$8.7M

Exited Positions (5)

TickerIssuerNotional
MRUSMERUS N V$153.5M
RACATHERAPEUTICS ACQUISITION COR$28.5M
FBRXFORTE BIOSCIENCES INC$19.9M
IMVTIMMUNOVANT INC$13.5M
CNTACENTESSA PHARMACEUTICALS PLC$1.3M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CRNXCRINETICS PHARMACEUTICALS IN$19.6M+3828.7%
AMRNXXXXAMARIN CORP PLC$50.7M+564.8%
IVAINVENTIVA SA$6.3M+408.9%
VRDNVIRIDIAN THERAPEUTICS INC$6.8M+129.7%
LXRXLEXICON PHARMACEUTICALS INC$30.5M+71.1%-51.8%
RAINRAIN THERAPEUTICS INC$14.0M+52.0%
ACRSACLARIS THERAPEUTICS INC$7.2M+37.3%-69.1%
VSTMXXXXVERASTEM INC$0.2M+32.7%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
RNACSELECTA BIOSCIENCES INC$-5.8M-81.1%
CRVSCORVUS PHARMACEUTICALS INC$-3.2M-62.7%
ANABANAPTYSBIO INC$-11.9M-58.7%
ARGXARGENX SE$-85.5M-43.8%+211.2%
RLAYRELAY THERAPEUTICS INC$-42.9M-30.3%-40.9%
ACIUAC IMMUNE SA$-21.2M-18.8%-62.6%
FWPAYFORWARD PHARMA A/S$-1.6M-18.1%
GRTSQGRITSTONE BIO INC$-0.2M-16.3%
← Back to Hedge Funds